You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 131 No. 2, February 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prognosis and Treatment of Peritonitis

Do We Need New Scoring Systems?

Thomas Koperna, MD; Franz Schulz, MD

Arch Surg. 1996;131(2):180-186.


Abstract

Objectives
To assess the clinical significance of present scoring systems for prognosis and treatment in patients with secondary bacterial peritonitis and to define risk factors for patient survival and outcome not included in the scores. A secondary objective was to review our therapeutic regimens and the need for reoperation with regard to outcome.

Design
Prospective observational study.

Setting
University hospital, secondary referral center.

Patients
From 1992 to 1995, 92 patients with secondary peritonitis were examined at the University Surgical Clinic, Vienna, Austria. The population as a whole consisted of 56 men and 36 women with an average age of 56±19 years. Forty-four percent of patients had postoperative peritonitis.

Outcome Measures
Mortality, multiple organ system failure (MOSF), relaparotomy.

Results
The mortality rate in patients with an APACHE II (Adult Physiology and Chronic Health Evaualtion) score of less than 15 was 4.8%, while mortality rose to 46.7% in those with a score of 15 or higher (P=.001). The average total mortality rate was 18.5%. The prognosis for patients without organ failure or with failure of one organ system was excellent (mortality rate, 0%); quadruple organ failure, however, had a mortality rate of 90%. Initial thrombocytopenia (<60x109/L), four-quadrant peritonitis, and diabetes mellitus were associated with significantly higher mortality. Leukopenia (white blood cells, <6x109/L) and inappropriate antibiotic therapy as determined by the antibiogram were mildly significant for higher mortality. The need for relaparotomy resulted in substantially higher mortality (P<.001). The impossibility of definitive operative resolution of the intra-abdominal pathologic findings at initial operation had no significant effect on mortality, possibly because planned reoperations were always carried out in those cases. For patients with definitive resolution at initial operation, it was possible to reduce the traditionally high mortality rate associated with relaparotomy on demand by making the decision for reexploration promptly, within the first 48 hours. Nevertheless, the 52.4% mortality rate observed in those cases was still much higher than the 33% found in patients who were not free of disease after the initial operation.

Conclusions
The prognosis in peritonitis is decisively influenced by the health status of the patient at the beginning of treatment and by any concomitant risk factors. As a result, a fairly accurate prediction of the outcome of the disease can initially be made on the basis of the APACHE II score and the MOSF score according to Goris. However, the certainty that severely ill patients with high scores often die has little clinical relevance, since it does not provide any therapeutic alternatives to the attending physician. The decision to perform a relaparotomy must be made as soon as possible, at least before MOSF emerges. Already existing MOSF will lead to the "point of no return."

(Arch Surg. 1996;131:180-186)



Author Affiliations

From the Department of General Surgery, University of Vienna, Austria.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Comparison of On-Demand vs Planned Relaparotomy Strategy in Patients With Severe Peritonitis: A Randomized Trial
van Ruler et al.
JAMA 2007;298:865-872.
ABSTRACT | FULL TEXT  

Timing of Reoperation for Patients With Severe Peritonitis
Dellinger
JAMA 2007;298:923-924.
FULL TEXT  

Evaluation of Procalcitonin for Predicting Septic Multiorgan Failure and Overall Prognosis in Secondary Peritonitis: A Prospective, International Multicenter Study
Rau et al.
Arch Surg 2007;142:134-142.
ABSTRACT | FULL TEXT  

Predictive Factors of Mortality Due to Polymicrobial Peritonitis With Candida Isolation in Peritoneal Fluid in Critically Ill Patients
Dupont et al.
Arch Surg 2002;137:1341-1346.
ABSTRACT | FULL TEXT  

Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis
Sotto et al.
J Antimicrob Chemother 2002;50:569-576.
ABSTRACT | FULL TEXT  

Circulating Mediators and Organ Function in Patients Undergoing Planned Relaparotomy vs Conventional Surgical Therapy in Severe Secondary Peritonitis
Zugel et al.
Arch Surg 2002;137:590-599.
ABSTRACT | FULL TEXT  

Tumor Necrosis Factor-Dependent Adhesions as a Major Protective Mechanism Early in Septic Peritonitis in Mice
Echtenacher et al.
Infect. Immun. 2001;69:3550-3555.
ABSTRACT | FULL TEXT  

Risk Stratification in Emergency Surgical Patients: Is the APACHE II Score a Reliable Marker of Physiological Impairment?
Koperna et al.
Arch Surg 2001;136:55-59.
ABSTRACT | FULL TEXT  

Emergency Surgery for Colon Cancer in the Aged
Koperna et al.
Arch Surg 1997;132:1032-1037.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.